Evidence map›Paper›PMID 30042196›Full record

ArticlemBio2018

Transposon Insertion Sequencing Elucidates Novel Gene Involvement in Susceptibility and Resistance to Phages T4 and T7 in

Lauren A Cowley, Alison S Low, Derek Pickard, Christine J Boinett, Timothy J Dallman, Martin Day, Neil Perry, David L Gally, Julian Parkhill, Claire Jenkins and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  11. Article
  12. Delving into defence: identifying theMicrobial genomics · 2021
    Article
  13. Spontaneous Phage Resistance in Avian PathogenicFrontiers in microbiology · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Engineered bacteriophages as programmable biocontrol agents.Current opinion in biotechnology · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Lauren A CowleyGastrointestinal Bacterial Reference Unit, Public Health England, London United Kingdom drlacowley@gmail.com.
Alison S LowDivision of Immunity and Infection, the Roslin Institute and Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Midlothian, United Kingdom.
Derek PickardWellcome Trust Sanger Institute, Hinxton, Cambridge United Kingdom.
Christine J BoinettWellcome Trust Sanger Institute, Hinxton, Cambridge United Kingdom.
Timothy J DallmanGastrointestinal Bacterial Reference Unit, Public Health England, London United Kingdom.
Martin DayGastrointestinal Bacterial Reference Unit, Public Health England, London United Kingdom.
Neil PerryGastrointestinal Bacterial Reference Unit, Public Health England, London United Kingdom.
David L GallyDivision of Immunity and Infection, the Roslin Institute and Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Midlothian, United Kingdom.
Julian ParkhillWellcome Trust Sanger Institute, Hinxton, Cambridge United Kingdom.ORCID 0000-0002-7069-5958
Claire JenkinsGastrointestinal Bacterial Reference Unit, Public Health England, London United Kingdom.
Amy K CainWellcome Trust Sanger Institute, Hinxton, Cambridge United Kingdom.
Public Health England · GBWellcome Sanger Institute · GBRoslin Institute · GBCenter for Disease Dynamics, Economics & Policy · US

Funding

Biotechnology and Biological Sciences Research Council P013740Medical Research Council G1100100Medical Research Council G1100100/1Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

Experiments using bacteriophage (phage) to infect bacterial strains have helped define some basic genetic concepts in microbiology, but our understanding of the complexity of bacterium-phage interactions is still limited. As the global threat of antibiotic resistance continues to increase, phage therapy has reemerged as an attractive alternative or supplement to treating antibiotic-resistant bacterial infections. Further, the long-used method of phage typing to classify bacterial strains is being replaced by molecular genetic techniques. Thus, there is a growing need for a complete understanding of the precise molecular mechanisms underpinning phage-bacterium interactions to optimize phage therapy for the clinic as well as for retrospectively interpreting phage typing data on the molecular level. In this study, a genomics-based fitness assay (TraDIS) was used to identify all host genes involved in phage susceptibility and resistance for a T4 phage infecting Shiga-toxigenic

Indexed as

Genes, BacterialHost-Parasite InteractionsBacteriophage T4Bacteriophage T7DNA Transposable ElementsEscherichia coli O157Mutagenesis, InsertionalSequence Analysis, DNADNA Transposable ElementsbacteriophageGram-negative bacteriamutagenesistransposonswhole-genome sequencing

Identifiers

PMID30042196
PMCPMC6058288
OpenAlexW2884342774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.